(a.) Of or pertaining to actuaries; as, the actuarial value of an annuity.
Example Sentences:
(1) The actuarial 5-year disease-free survival rates were 83% (group 1), 83% (group 2), and 100% (group 3).
(2) This activity scheme uses as its base, dose potency measured as TD50, the chronic dose rate that actuarially halves the adjusted percentage of tumor-free animals at the end of the study (Gold et al., Environ.
(3) The actuarial 4-year rate of continuous disease control above the clavicles was 78% for Stage II.
(4) T1 and T2 cases, with an actuarial survival of 44% at five years, had a significantly better prognosis than T3 cases (31%) and T4 cases (10%).
(5) Five-year actuarial survival rates were 67%, 60%, and 38%, respectively.
(6) A second device was implanted in 41 patients with residual flow, and 37 of these had complete occlusion, giving an overall latest follow-up occlusion rate of 77% and an actuarial complete occlusion rate for one or two devices of 94.8% (95% Cl 92.9 to 96.7) at 30 months after implantation of the first device.
(7) The five- and ten-year actuarial survival of all patients was 50% and 46%, respectively.
(8) The marked improvement during recent years in prognosis for patients with insulin-dependent diabetes mellitus (IDDM), has also had actuarial consequences.
(9) Relapse following second and subsequent remission BMT was predicted by a score based on standard prognostic features or by the pace of the disease: patients with an interval of less than 2 years between diagnosis and first relapse having a 15% actuarial disease-free survival, compared with 81% for patients with an interval greater than 2 years (P less than 0.001).
(10) Thirteen (36%) of the 36 patients died before adequate antifungal therapy could be administered, while 13 survived long enough to receive 1,500 mg of amphotericin B; actuarial survival of the latter group from the date 1,500 mg of amphotericin B had been infused was 47% at 1 year.
(11) The 5-year actuarial survival for Stage IIA was 86% and the 5-year actuarial survival for Stage IIB was 46% (p = 0.06).
(12) Actuarial observed 2 yr. survival is 33% and the median survival is 15 months.
(13) The actuarial 5- and 10-year survival was 77 and 65%, respectively with 55 and 48% 5 and 10 year disease-free survival.
(14) The overall actuarial survival rate was 86.5% at 5 years and 78.0% at 10 years.
(15) The results indicate that half or more of the interstate differences in spending for this population group are due to actuarial and efficiency factors rather than deviations from equity potential.
(16) Utilizing these guidelines, a 1-year actuarial survival following each of these procedures of greater than 60% can be expected.
(17) Five-year actuarial survival rates were 86.6% for frank, 98.8% for microinvasive and 98.8% for in situ carcinomas.
(18) Patients with one or more of the above risk factors who received BMT have a disease-free survival of 61% with a median follow-up of 66 months (range 11 months to 10.6 years), and an actuarial relapse rate of 10%.
(19) The actuarial survival at 2 years after grafting of Blacks, Hispanics and Asians was compared with that of Caucasians transplanted between 1971 and 1985 for aplastic anaemia, acute non-lymphocytic leukaemia and acute lymphoblastic leukaemia.
(20) Actuarial 5-year survival was 90% for pT1, 51% for pT2 and 34% for pT3, bladder treatment being unsuccessful in 6 cases (11%).
Actuary
Definition:
(n.) A registrar or clerk; -- used originally in courts of civil law jurisdiction, but in Europe used for a clerk or registrar generally.
(n.) The computing official of an insurance company; one whose profession it is to calculate for insurance companies the risks and premiums for life, fire, and other insurances.
Example Sentences:
(1) The actuarial 5-year disease-free survival rates were 83% (group 1), 83% (group 2), and 100% (group 3).
(2) This activity scheme uses as its base, dose potency measured as TD50, the chronic dose rate that actuarially halves the adjusted percentage of tumor-free animals at the end of the study (Gold et al., Environ.
(3) The actuarial 4-year rate of continuous disease control above the clavicles was 78% for Stage II.
(4) T1 and T2 cases, with an actuarial survival of 44% at five years, had a significantly better prognosis than T3 cases (31%) and T4 cases (10%).
(5) Five-year actuarial survival rates were 67%, 60%, and 38%, respectively.
(6) A second device was implanted in 41 patients with residual flow, and 37 of these had complete occlusion, giving an overall latest follow-up occlusion rate of 77% and an actuarial complete occlusion rate for one or two devices of 94.8% (95% Cl 92.9 to 96.7) at 30 months after implantation of the first device.
(7) The five- and ten-year actuarial survival of all patients was 50% and 46%, respectively.
(8) The marked improvement during recent years in prognosis for patients with insulin-dependent diabetes mellitus (IDDM), has also had actuarial consequences.
(9) Relapse following second and subsequent remission BMT was predicted by a score based on standard prognostic features or by the pace of the disease: patients with an interval of less than 2 years between diagnosis and first relapse having a 15% actuarial disease-free survival, compared with 81% for patients with an interval greater than 2 years (P less than 0.001).
(10) Thirteen (36%) of the 36 patients died before adequate antifungal therapy could be administered, while 13 survived long enough to receive 1,500 mg of amphotericin B; actuarial survival of the latter group from the date 1,500 mg of amphotericin B had been infused was 47% at 1 year.
(11) The 5-year actuarial survival for Stage IIA was 86% and the 5-year actuarial survival for Stage IIB was 46% (p = 0.06).
(12) Actuarial observed 2 yr. survival is 33% and the median survival is 15 months.
(13) The actuarial 5- and 10-year survival was 77 and 65%, respectively with 55 and 48% 5 and 10 year disease-free survival.
(14) The overall actuarial survival rate was 86.5% at 5 years and 78.0% at 10 years.
(15) The results indicate that half or more of the interstate differences in spending for this population group are due to actuarial and efficiency factors rather than deviations from equity potential.
(16) Utilizing these guidelines, a 1-year actuarial survival following each of these procedures of greater than 60% can be expected.
(17) Five-year actuarial survival rates were 86.6% for frank, 98.8% for microinvasive and 98.8% for in situ carcinomas.
(18) Patients with one or more of the above risk factors who received BMT have a disease-free survival of 61% with a median follow-up of 66 months (range 11 months to 10.6 years), and an actuarial relapse rate of 10%.
(19) The actuarial survival at 2 years after grafting of Blacks, Hispanics and Asians was compared with that of Caucasians transplanted between 1971 and 1985 for aplastic anaemia, acute non-lymphocytic leukaemia and acute lymphoblastic leukaemia.
(20) Actuarial 5-year survival was 90% for pT1, 51% for pT2 and 34% for pT3, bladder treatment being unsuccessful in 6 cases (11%).